Inovio Pharmaceuticals, Inc. (INO): Total Assets
$74.31M
As of 2025-12-31
$49.39M
As of 2026-06-30
-40.3%
3-year compound annual growth
-32.7%
5-year compound annual growth
-10.0%
10-year compound annual growth
| Period ended | Total Assets | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $74.31M | -34.4% | 2026-03-12, Balance as of period end |
| 2024-12-31 | $113.20M | -33.8% | 2026-03-12, Balance as of period end |
| 2023-12-31 | $170.95M | -51.0% | 2025-03-18, Balance as of period end |
| 2022-12-31 | $348.53M | -29.7% | 2024-03-06, Balance as of period end |
| 2021-12-31 | $495.94M | -8.1% | 2023-03-01, Balance as of period end |
| 2020-12-31 | $539.77M | +275.0% | 2022-03-01, Balance as of period end |
| 2019-12-31 | $143.95M | +9.8% | 2021-03-01, Balance as of period end |
| 2018-12-31 | $131.11M | -30.0% | 2020-03-12, Balance as of period end |
| 2017-12-31 | $187.24M | +7.8% | 2019-03-12, Balance as of period end |
| 2016-12-31 | $173.71M | -18.8% | 2018-03-14, Balance as of period end |
| 2015-12-31 | $213.84M | +62.3% | 2017-03-15, Balance as of period end |
| 2014-12-31 | $131.79M | +49.3% | 2016-03-14, Balance as of period end |
| 2013-12-31 | $88.29M | +95.6% | 2015-03-16, Balance as of period end |
| 2012-12-31 | $45.14M | -26.1% | 2014-03-17, Balance as of period end |
| 2011-12-31 | $61.11M | +9.0% | 2013-03-18, Balance as of period end |
| 2010-12-31 | $56.07M | n/a | 2012-03-15, Balance as of period end |
Total Assets at similar companies
| Company | Year ended | Total Assets | Change YoY |
|---|---|---|---|
| Inovio Pharmaceuticals, Inc. (INO) | 2025-12-31 | $74.31M | -34.4% |
| Connect Biopharma Holdings Ltd (CNTB) | 2025-12-31 | $56.08M | -44.6% |
| Silo Pharma, Inc. (SILO) | 2025-12-31 | $7.61M | +2.6% |
| Avalo Therapeutics, Inc. (AVTX) | 2025-12-31 | $116.46M | -22.7% |
| HCW Biologics Inc. (HCWB) | 2025-12-31 | $24.52M | -18.9% |
| Incannex Healthcare Inc. (IXHL) | 2025-06-30 | $20.45M | +19.9% |
| Actinium Pharmaceuticals, Inc. (ATNM) | 2025-12-31 | $51.77M | -32.7% |
| iBio, Inc. (IBIO) | 2026-06-30 | $99.11M | +327.5% |
| Altimmune, Inc. (ALT) | 2025-12-31 | $279.93M | +100.9% |
Compare INO, CNTB, SILO, AVTX side by side · Screen every company in Pharmaceutical Preparations ↗